The FDA will testify in favor of regulating laboratory developed tests at a House Energy and Commerce subcommittee meeting on Tuesday. The agency put out a collection of case studies supporting the position ahead of its testimony.
Texas Medical Board president Michael Arambula, MD publishes a letter in the Statesman responding to recent criticism of its telemedicine policies. The board requires an in-person visit establishing a patient-provider relationship before remote visits are authorized. Though there are situational exceptions to the rule, the policy has the effect of restricting telehealth vendors, like Dallas-based Teladoc, from effectively operating in the state.
Healthcare Finance profiles Money Atwal, former CIO/CFO of Hawaii Health Systems. Atwal oversaw the health system’s Meditech 6.0 implementation, earning HIMSS Stage 7 status and a 2015 Davies Award. As a CFO, he used technology to drive accounts receivable days down from 200 to 54.